Administation of antibiotics via the respiratory tract as monotherapy for pneumonia

Expert Review of Anti-Infective Therapy

Volumn 6, Issue 4, 2008, Pages 447-452

  Falagas, Matthew E ^a,b   Agrafiotis, Michalis ^a   Athanassa, Zoe ^a   Siempos, Ilias I ^a  

^a Alfa Institure of Biomedical Sciences (AIBS)   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gram negative bacteria; Intensive care unit; Multidrug resistance; Ventilator associated pneumonia

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; NETILMICIN; PENICILLIN G; PIPERACILLIN; POLYMYXIN; SALBUTAMOL; STREPTOMYCIN; TERBUTALINE; TICARCILLIN; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERIUM ISOLATION; BRONCHITIS; BRONCHOSPASM; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; DRUG ADMINISTRATION ROUTE; GLOSSITIS; HUMAN; LUNG LAVAGE; MONOTHERAPY; PNEUMONIA; PSEUDOMONAS AERUGINOSA; SPUTUM; STOMATITIS; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; BACTERIAL PNEUMONIA; INHALATIONAL DRUG ADMINISTRATION; RESPIRATORY SYSTEM; REVIEW; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ANTI-BACTERIAL AGENTS; HUMANS; PNEUMONIA, BACTERIAL; RESPIRATORY SYSTEM; TREATMENT OUTCOME;

EID: 54449097649     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.6.4.447     Document Type: Article

References (19)

1. Ventre K, Randolph AG. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst. Rev. 1, CD000181 (2007).
2. O'Riordan TG. Inhaled antimicrobial therapy: from cystic fibrosis to the flu. Respir. Care 45, 836-845 (2000).
3. Klepser ME. Role of nebulized antibiotics for the treatment of respiratory infections. Curr. Opin. Infect. Dis. 17, 109-112 (2004).
4. Falagas ME, Siempos II, Bliziotis IA, Michalopoulos A. Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials. Crit. Care 10, R123 (2006).
5. Falagas ME, Siempos II. Prevention of ventilator-associated pneumonia: possible role of antimicrobials administered via the respiratory tract. Eur. Respir. J. 31, 1138-1139 (2008).
6. Ioannidou E, Siempos II, Falagas ME. Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis. J. Antimicrob. Chemother. 60, 1216-1226 (2007).
7. Farber JE, Ross J. The use of aerosol penicillin and streptomycin in bronchopulmonary infections. Calif. Med. 73, 214-217 (1950).
8. Mastersky J, Geuning C, Mouawad. E, Daneau D. Endotracheal gentamicin in bronchial infections in patients with tracheostomy. Chest 61, 117-120 (1972).
9. McCall CY, Spruill WJ, Wade WE. The use of aerosolized tobramycin in the treatment of a resistant pseudomonal pneumonitis. Ther. Drug Monit. 11, 692-695 (1989).
10. Standridge JB, Aliff CL. Aerosolized amikacin in the treatment of Pseudomonas pneumonia in the nursing home setting. South Med. J. 94, 244-246 (2001).
11. Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit. Care 9, R53-R59 (2005).
12. Berlana D, Llop JM, Fort E, Badia MB, Jodar R. Use of colistin in the treatment of multiple-drug-resistant Gram-negative infections. Am. J. Health Syst. Pharm. 62, 39-47 (2005).
13. Kwa AL, Loh C, Low JG, Kurup A, Tam VH. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin. Infect. Dis. 41, 754-757 (2005).
14. Larsson S, Svedmyr N. Bronchodilating effect and side effects of β2-adrenoceptor stimulants by different modes of administration. Am. Rev. Respir. Dis. 116, 861-869 (1977).
15. Falagas ME, Kasiakou SK. Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis. Infection 35, 3-10 (2007).
16. Pines A, Raafat H, Plucinski K. Gentamicin and colistin in chronic purulent bronchial infections. BMJ 2, 543-545 (1967).
17. Michalopoulos A, Kasiakou SK, Falagas ME. The significance of different formulations of aerosolized colistin. Crit. Care 9, 417-418 (2005).
18. Dhand R. The role of aerosolized antimicrobials in the treatment of ventilator-associated pneumonia. Respir. Care 52, 866-884 (2007).
19. Brown RB, Phillips D, Barker MJ, Pieczarka. R, Sands M, Teres D. Outbreak of nosocomial Flavobacterium meningosepticum respiratory infections associated with use of aerosolized polymyxin B. Am. J. Infect. Control 3, 121-125 (1989).